• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

男男性行为者基于事件剂量的 HIV 暴露前预防用药的性传播感染检测和流行率

Sexually transmitted infection testing and prevalence among MSM using event-based dosing HIV pre-exposure prophylaxis.

机构信息

Department of Sexual Health & HIV Medicine, University Hospitals Sussex NHS Foundation Trust, Brighton BN2 5BE, UK.

Department of Sexual Health & HIV Medicine, University Hospitals Sussex NHS Foundation Trust, Brighton BN2 5BE, UK; and Brighton & Sussex Medical School, Brighton, UK.

出版信息

Sex Health. 2023 Apr;20(2):177-179. doi: 10.1071/SH22192.

DOI:10.1071/SH22192
PMID:36709761
Abstract

Event-based dosing (EBD) of HIV PrEP is as effective at preventing HIV transmission in MSM as daily dosing. There are limited data on the differences in STI testing frequency between MSM using EBD-PrEP and daily dosing. A total of 20% of 418 PrEP users were using EBD-PrEP and had a lower number of sexual partners (22 (27%) vs 142 (42%), P =0.008), tested for STIs less frequently (115 (18%) vs 69 (50%), P <0.001), but were diagnosed with a similar number of STIs ((35% vs 34%, P =0.54) compared to daily users. More research is needed to understand the optimal frequency for STI testing in MSM using EBD PrEP.

摘要

基于事件的艾滋病预防药物剂量调整(EBD)在男男性行为者(MSM)中的预防艾滋病效果与每日剂量相当。目前关于使用 EBD-PrEP 和每日剂量的 MSM 之间性传播感染(STI)检测频率差异的数据有限。在 418 名 PrEP 用户中,共有 20%的人使用 EBD-PrEP,他们的性伴侣数量较少(22 人(27%)与 142 人(42%),P=0.008),接受 STI 检测的频率较低(115 人(18%)与 69 人(50%),P<0.001),但诊断出的 STI 数量相似(35%与 34%,P=0.54)与每日使用者相比。需要进一步研究来了解 EBD PrEP 使用者的最佳 STI 检测频率。

相似文献

1
Sexually transmitted infection testing and prevalence among MSM using event-based dosing HIV pre-exposure prophylaxis.男男性行为者基于事件剂量的 HIV 暴露前预防用药的性传播感染检测和流行率
Sex Health. 2023 Apr;20(2):177-179. doi: 10.1071/SH22192.
2
Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.每日用药和按需用药预防方案下男男性行为者的性行为特征和艾滋病毒及性传播感染发病率:AMPrEP 研究两年结果。
Lancet HIV. 2019 Jul;6(7):e447-e455. doi: 10.1016/S2352-3018(19)30136-5. Epub 2019 Jun 6.
3
Trends in Sexual Behavior and Sexually Transmitted Infections After Initiating Human Immunodeficiency Virus Pre-Exposure Prophylaxis in Men Who Have Sex with Men from Amsterdam, the Netherlands: A Longitudinal Exposure-Matched Study.在荷兰阿姆斯特丹的男男性行为者中启动人类免疫缺陷病毒暴露前预防后性行为和性传播感染趋势:一项纵向暴露匹配研究。
AIDS Patient Care STDS. 2022 Jun;36(6):208-218. doi: 10.1089/apc.2021.0219.
4
Factors Associated With Willingness to Use Daily Antibiotics as Sexually Transmitted Infection Prophylaxis Among HIV Preexposure Prophylaxis-Experienced Gay and Bisexual Men in Australia.澳大利亚有HIV暴露前预防经验的男同性恋者和双性恋男性中,与将每日使用抗生素作为性传播感染预防措施的意愿相关的因素。
Sex Transm Dis. 2023 Mar 1;50(3):144-149. doi: 10.1097/OLQ.0000000000001731. Epub 2022 Nov 6.
5
Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort.首次接受 HIV 暴露前预防咨询时使用 PrEP 的人群特征:CSL-PrEP 队列研究。
BMJ Open. 2022 Dec 20;12(12):e067261. doi: 10.1136/bmjopen-2022-067261.
6
HIV, STI and renal function testing frequency and STI history among current users of self-funded HIV pre-exposure prophylaxis, a cross-sectional study, Germany, 2018 and 2019.在德国,2018 年和 2019 年进行的一项横断面研究,调查了自费 HIV 暴露前预防(PrEP)使用者的 HIV、性传播感染(STI)和肾功能检测频率以及 STI 史。
Euro Surveill. 2022 Apr;27(14). doi: 10.2807/1560-7917.ES.2022.27.14.2100503.
7
HIV pre-exposure prophylaxis and diagnoses of sexually transmitted infections - observational data from German checkpoints, 01/2019-08/2021.HIV 暴露前预防和性传播感染诊断 - 来自德国检查站的观察数据,2019 年 1 月至 2021 年 8 月。
BMC Public Health. 2023 Apr 7;23(1):661. doi: 10.1186/s12889-023-15570-6.
8
Incident Cases of Sexually Transmitted Infections among Users of Pre-Exposure Prophylaxis for HIV Prevention in Honolulu, Hawai'i.檀香山预防性暴露前预防 HIV 感染使用者的性传播感染事件案例。
Hawaii J Health Soc Welf. 2021 Jul;80(7):148-154.
9
Impact of Providing Preexposure Prophylaxis for Human Immunodeficiency Virus at Clinics for Sexually Transmitted Infections in Baltimore City: An Agent-based Model.巴尔的摩市性传播感染诊所提供人类免疫缺陷病毒暴露前预防的影响:基于主体的模型。
Sex Transm Dis. 2018 Dec;45(12):791-797. doi: 10.1097/OLQ.0000000000000882.
10
HIV pre-exposure prophylaxis was associated with no impact on sexually transmitted infection prevalence in a high-prevalence population of predominantly men who have sex with men, Germany, 2018 to 2019.2018 年至 2019 年,在以男男性行为者为主的高感染率人群中,HIV 暴露前预防并未对性传播感染的流行率产生影响,德国。
Euro Surveill. 2022 Apr;27(14). doi: 10.2807/1560-7917.ES.2022.27.14.2100591.

引用本文的文献

1
Demographics, Trends, and Clinical Characteristics of HIV Pre-Exposure Prophylaxis Recipients and People Newly Diagnosed with HIV from Large Electronic Health Records in Florida.佛罗里达州大型电子健康记录中 HIV 暴露前预防接受者和新诊断 HIV 患者的人口统计学、趋势和临床特征。
AIDS Patient Care STDS. 2024 Jan;38(1):14-22. doi: 10.1089/apc.2023.0220.